| Literature DB >> 32476811 |
Lucie Riedlbauchová1,2, Václav Durdil1,2, Jakub Honěk1,2, Josef Veselka1,2.
Abstract
Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention. © Thieme Medical Publishers.Entities:
Keywords: AV junctional ablation; ICD; atrial fibrillation; cardiac pacing; cardiac resynchronization; heart failure; sick sinus syndrome
Year: 2020 PMID： 32476811 PMCID： PMC7250633 DOI： 10.1055/s-0040-1708529
Source DB: PubMed Journal: Int J Angiol ISSN： 1061-1711